Early Clinical Outcomes of the DePuy ACTIS Total Hip Arthroplasty Femoral Implant.

Abstract

Early clinical outcomes were assessed for patients who underwent total hip arthroplasty (THA) with the recently released DePuy ACTIS femoral stem for primary osteoarthritis performed through a direct anterior approach. From 2017 to 2018, 226 THAs were retrospectively reviewed on patients with at least one year of postoperative follow-up (average follow-up time was 2.63 years [+/- 0.83]). The primary outcome measure was all-cause revision rate (1.91%), observing for failures related to dislocation (0.48%), aseptic loosening (0.48%), pain (0.48%), infection (0.0%), and fracture (0.48%). Mean preoperative Visual Analogue Scale scores were 6.07 (+/- 2.37) compared with 0.62 (+/- 1.5) postoperatively (p < 0.001). The DePuy ACTIS THA femoral implant demonstrated encouraging early clinical outcomes. Further follow-up and surveillance will evaluate how this stem compares with others in the market, but this study demonstrates reliability in evaluation of short-term outcomes. (Journal of Surgical Orthopaedic Advances 34(3):128-129, 2025).